0.8678USD+20.16%Mkt Cap: 103.31M USDP/E: —Last update: 2026-06-01
Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications. Its lead product candidate is ONS-5010, an o…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap103.31M USD
Enterprise Value107.66M USD
Revenue (TTM)333.14K USD
Gross Profit57.20K USD
Net Income (TTM)-62.42M USD
Revenue/Share0.0060 USD
Last Price0.8678 USD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees17
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.74
PEG—
EV/EBITDA-1.78
EV/Revenue323.18
P/S325.59
P/B-2.64
EPS (TTM)-1.13
EPS (Forward)-0.27
52W Range
0.161022% of range3.390
52W High3.390 USD
52W Low0.1610 USD
Profitability
Gross Margin4.05%
Oper. Margin-11006.82%
EBITDA Margin0.00%
Profit Margin-4416.22%
ROE193.94%
ROA-335.90%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-51.83M USD
CapEx (TTM)—
FCF Margin-7645.84%
FCF Yield-24.65%
Net Debt19.44M USD
Net Debt/EBITDA-0.32
Balance Sheet
Debt/Equity-0.94
Current Ratio0.54
Quick Ratio0.27
Book Value/Sh-0.2770 USD
Cash/Share0.0640 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateMar 18, 2019
Splits
Last Split1:20
Split DateMar 14, 2024
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)4.167 USD
Target Range0.5000 USD – 6.000 USD
# Analysts3
Ownership
Shares Out.120.86M
Float105.53M
Insiders15.99%
Institutions9.17%
Short Interest
Short Ratio1.9d
Short % Float7.52%
Short % Out.7.52%
Shares Short9.09M
Short (prev mo.)4.69M
Technical
SMA 500.2772 (+213.0%)
SMA 2000.9621 (-9.8%)
Beta0.33
S&P 52W Chg27.94%
Avg Vol (30d)22.76M
Avg Vol (10d)58.40M
Technical Indicators
RSI (14)81.4
MACD0.0819
MACD Signal0.0260
MACD Hist.+0.0559
BB Upper0.6362 USD
BB Middle0.3176 USD
BB Lower-0.0009 USD
BB Width200.58%
ATR (14)0.0753 USD
Vol Ratio (20d)0.98x